SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2611Indeed. The dog barked, and that was the surprising thing.tom pope-4/23/2010
2610From the AH reaction, I'd form the exact opposite impression.Ian@SI-4/23/2010
2609From the briefing docs, that could not have been unexpected.tom pope-4/22/2010
2608ACUR down 50%+ AH 4:25PM Acura Pharma and King Pharmaceuticals provide update oIan@SI-4/22/2010
2607mipi more profit taking, down 17% today.mopgcw-4/16/2010
2606almost 2:1 market split for SNTS AH on news... Santarus Announces District CourIan@SI-4/14/2010
2605Molecular Insight (MIPI), off 20% today after being up huge -- 145% -- yesterdaytuck-4/14/2010
2604GNVC:1. GenVec shares implode on pancreatic cancer trial failure By Maureen Marmlkr-4/1/2010
2603Been digging around a little. Thot I might pick up a small position if it's fred hayes-3/30/2010
2602Possibly. They've been working in the bioterror area, if memory serves, gettuck-3/29/2010
2601Looks like tomorrow's MC will be sub $100 million. Don't follow this onefred hayes-3/29/2010
2600GenVec face plants on trial P# halt of TNFerade, due to futility at interim. 78tuck-3/29/2010
2599ASA404 has had a tortuous history; details with some hyperlinks in: siliconinvesDewDiligence_on_SI-3/29/2010
2598LONDON, March 29 (Reuters) - British cancer specialist Antisoma suffered a majornigel bates-3/29/2010
2597Seems like their new corporate policy is to lay off 50% of the remaining staff eDewDiligence_on_SI-3/24/2010
2596PARD off only 20% as we approach the close. 8:33AM Poniard Pharma suspends effoIan@SI-3/24/2010
2595Vernalis, 20%: "...Vernalis plc (LSE: VER), a development stage pharmaceutnigel bates-3/24/2010
2594RXII off 27% on a financing: >>WORCESTER, Mass. (AP) -- RXi Pharmaceuticatuck-3/23/2010
2593Oncothyreon (ONTY) spluts 26% on Merck Serono clinical suspension of StimuVax trtuck-3/23/2010
2592Per the briefing docs, yeah, you're right. I was remembering the RAPID triatuck-3/22/2010
2591I would disagree with you. Not much of a shame here. They didn't even prove rkrw-3/22/2010
2590Did you follow the Feuerstein blog of the meeting? There are some true believerstom pope-3/22/2010
2589CTIC off something like 45% on negative panel vote for Pixantrone. A shame. Hatuck-3/22/2010
2588appa on CRL for vomiting, down over 50 percent.fred hayes-3/19/2010
2587Vectura 20%, as Novartis drops generic Advair in the US: Chippenham, UK - 18 Manigel bates-3/18/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News